NCT03601221View on ClinicalTrials.gov

Seroprevalence Hepatitis E Infection in Healthy Blood Donors

CompletedOBSERVATIONAL
Enrollment

1,447

Participants

Timeline

Start Date

May 29, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2019

Conditions
Hepatitis E
Interventions
OTHER

Sample collection

Collection of one sampling pouch from each blood donor

Trial Locations (1)

6900

Swiss Transfusion SRC Canton Ticino, Lugano

All Listed Sponsors
collaborator

Swiss Transfusion SRC

OTHER

collaborator

Clinical Trial Unit Ente Ospedaliero Cantonale

OTHER

lead

Ente Ospedaliero Cantonale, Bellinzona

OTHER

NCT03601221 - Seroprevalence Hepatitis E Infection in Healthy Blood Donors | Biotech Hunter | Biotech Hunter